ALS trials
Have you ever considered participating in a clinical trial (study) and thus contributing to medical research?
Clinical trials: between facts and fiction - Click here
What is new in the treatment of ALS? - Click here
Info experimental studies
Clinical trials in Belgium...
PRECISION-ALS Active and recruiting
QRL-201Active and recruiting
CARDINALS Active nut not recruiting
ActiSLA-studie-CHR-Citadelle-Luik Active and recruiting
AP101-studie Active and recruiting
Corcept Therapeutics DAZALS studie met CORT113176 (dazucorilant) Active nut not recruiting
Amylyx - Phoenix Active nut not recruiting
Ferrer ADORE study infographic
Studie met TPN-101 in C9orf72 ALS en/of FTD Active nut not recruiting
Wave FOCUS-C9 studie met C9orf72 ASO in ALS en FTD discontinued
HIMALAYA-studie Active and recruiting
MAGNET-studie Active and recruiting
Cytokinetics COURAGE studie met Reldesemtiv discontinued
Ferrer ADORE studie met FAB122 (orale vorm edaravone) Active nut not recruiting
Biogen ATLAS studie met ASO met presymptomatische SOD1 dragers Completed
Ionis FUSION studie met FUS ASO Active and recruiting
Apellis MERIDIAN studie met pegcetacoplan in ALS discontinued
Alexion CHAMPION-ALS studie discontinued
Orphazyme Arimoclomol (ORARIALS-01) fase III studie Completed
Biogen SOD1 ASO Afgerond Compassionate Use programma
Biogen Methodologie studie Completed
PESA studie Active and recruiting
PYRAMID (Phenotype Research for ALS Modifyer Discovery) studie Active and recruiting
TUDCA studie Completed
Clinical trials abroad in collaboration with the league
PRODUCT | STUDIE | STATUS | END DATE | RESPONSIBLE FIRM, UNIV, CLINIC OR COUNTRY |
Antiretroviral |
X | Recruiting | 02/2023 | NINDS, Australia |
Autologe Stamcellen |
X | Recruiting | US, Korea | |
Allogene Stamcellen |
X | Caribbean, universities | ||
AP101-02 | Recruiting | 01/2025 | AL-S Pharma | |
BIIB105 | ALSpire | Active Not Recruiting | 07/2026 | Biogen/Ionis |
Cannabinoids | EMERALD | Active Not Recruiting | 01/2024 | Australia |
CU(II)ATSM | Active Not Recruiting | 12/2022 | Coll Med Dev Australia | |
Dazucorilant | DAZALS | Active Not Recruiting | STOP 18/11/2023 | Corcept Therapeutics |
Deferiprone | FAIR-ALS II | Recruiting | 04/2022 | France |
Fasudil | ROCK REAL | Active Not Recruiting | 1/2023 | Germany, France, US |
GDNF | Recruiting | 09/2025 | Cedars Sinai | |
Healey Platform Trial | HEALEY | Recruiting | 07/2024 | NEALS |
Ibudilast (MN-166) | COMBAT-ALS | Recruiting | 12/2024 | MediciNova |
ION363 fus | FUSION | Recruiting | 03/2028 | Ionis |
Lithium Magnet | MAGNET | Recruiting | 06/2024 | Tricals |
Masinitib | Recruiting | 12/2023 | AB Science | |
Memantine and Trazodone | SMART | Recruiting | 12/2026 | UK |
Presymptomatic sod1 | ATLAS | Recruiting | 08/2027 ... |
Biogen |
Q-cells |
ALTA BOLT | Not Yet Recruiting | 12/2025 | Q Therapeutics |
QRL-201 | Recruiting | 05/2025 | QurAlis | |
RNS60 | Not Yet Recruiting | 06/2026 | Italy and US | |
BIIB067 Long Term sod1 | Active Not Recruiting | 06/2024 | Biogen/Ionis | |
TPN-101 C9 | Transposon | Completed | 09/2023 | Transposon |
VRG | Recruiting | 06/2026 | Verge Genomics |